CERUS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.68 USD | -0.59% |
|
0.00% | -22.22% |
Chart calendar Cerus Corporation
51e.InnkeAe4C1hD5J2Q7ARd6Thpwn7Es9nVrGix21Isc9g.FkmpKjaMR2khhcrZu30uvQ8Yrk6K_euvnwHEtmVfBb1wF70sSfU6LCndqQ~bd6399dd7147b099b0f0243ef7a1cea6
Upcoming events on Cerus Corporation
Past events on Cerus Corporation
| 2024-03-19 09:00 am | INTERCEPT Blood System for Red Blood Cells in Cardiovascular Phase III Clinical Trial Results Call |
| 2024-03-06 11:10 am | TD Cowen Health Care Conference |
| 2024-03-05 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-05 04:00 pm | Q4 2023 Earnings Release |
| 2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 2023-11-15 01:00 pm | Stephens Investment Conference - Fireside Chat |
| 2023-11-14 04:10 pm | Stifel Healthcare Conference - Fireside Chat |
| 2023-11-02 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-02 04:00 pm | Q3 2023 Earnings Release |
| 2023-10-16 05:30 pm | Association for the Advancement of Blood & Biotherapies Meeting - Implementation Of 100% Pathogen-Re |
| 2023-10-16 07:00 am | Association for the Advancement of Blood & Biotherapies Meeting - Expanding the Use of Pathogen Redu |
| 2023-10-15 10:00 am | Association for the Advancement of Blood & Biotherapies Meeting - Pathogen Reduced Cryoprecipitate |
| 2023-09-26 10:30 am | Cantor Global Healthcare Conference |
| 2023-08-02 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-02 04:00 pm | Q2 2023 Earnings Release |
| 2023-06-21 03:15 am | Regional International Society of Blood Transfusion Congress |
| 2023-06-19 06:30 am | Regional International Society of Blood Transfusion Congress |
| 2023-06-07 12:00 pm | Annual General Meeting |
| 2023-05-04 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-04 04:00 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 74,6 74,1 0.72% | 91,9 90,7 1.34% | 131 131 -0.03% | 162 170 -4.48% | 156 175 -10.44% | 179 |
|
EBITDA Million USD | Released Forecast Spread | -63,8 0,00 - | -55,2 0,00 - | -45,8 -28,5 -60.61% | -12,4 -9,15 -36.05% | -10,7 -13,1 18.16% | 6,49 |
|
EBIT Million USD | Released Forecast Spread | -66,2 -66,6 0.5% | -58,3 -58,1 -0.47% | -48,9 -54,6 10.39% | -34,1 -32,3 -5.47% | -30,1 -32,1 6.37% | -13,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -71,0 -70,9 -0.13% | -59,6 -59,9 0.59% | -54,1 -58,6 7.78% | -42,3 -38,2 -10.93% | -37,3 -39,5 5.4% | -19,9 |
|
Net income Million USD | Released Forecast Spread | -71,2 -71,1 -0.23% | -59,9 -60,1 0.43% | -54,4 -58,9 7.62% | -42,8 -38,3 -11.58% | -37,5 -39,8 5.75% | -20,1 |
|
EPS USD | Released Forecast Spread | -0,51 -0,51 -0.66% | -0,37 -0,37 -0.68% | -0,32 -0,35 7.25% | -0,24 -0,22 -10.34% | -0,21 -0,22 5.62% | -0,11 |
| Announcement Date | 20/02/20 | 25/02/21 | 22/02/22 | 28/02/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 39,9 39,9 -0.09% | 37,4 37,5 -0.12% | 41,0 42,8 -4.11% | 39,6 40,2 -1.53% | 44,0 43,5 1.3% | 31,0 37,0 -16.3% | 38,9 41,8 -7% | 39,8 42,8 -7% | 46,8 52,0 -10.03% | 38,3 | 44,3 | 45,6 | 50,4 | 40,9 |
|
EBITDA Million USD | Released Forecast Spread | -6,15 -5,90 -4.17% | -3,66 -7,38 50.41% | -2,41 -4,04 40.2% | -2,68 -2,50 -7.06% | -3,70 -1,03 -258.26% | -9,75 -4,97 -96.39% | -4,74 -5,17 8.29% | -0,97 -3,51 72.34% | 4,74 2,39 98.47% | -1,92 | 1,20 | 1,77 | 5,44 | -1,79 |
|
EBIT Million USD | Released Forecast Spread | -6,96 -12,6 44.96% | -9,85 -14,2 30.87% | -6,84 -11,0 38.01% | -7,45 -9,29 19.85% | -9,95 -8,20 -21.29% | -14,1 -13,2 -7.4% | -9,51 -9,27 -2.57% | -5,24 -8,33 37.09% | 0,98 -2,13 145.76% | -7,26 | -4,15 | -2,93 | 0,93 | -7,72 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,05 -13,6 33.52% | -12,2 -14,4 15.44% | -8,32 -12,4 32.68% | -8,45 -10,6 20.17% | -13,4 -9,24 -44.57% | -15,6 -15,9 1.94% | -13,2 -10,9 -21.72% | -7,21 -9,74 26.01% | -1,32 -4,66 71.72% | -8,88 | -5,75 | -4,54 | -0,68 | -9,09 |
|
Net income Million USD | Released Forecast Spread | -9,12 -13,6 33.11% | -12,3 -14,5 15.46% | -8,39 -12,4 32.34% | -8,48 -10,6 20.05% | -13,6 -9,24 -47.45% | -15,6 -14,7 -6.51% | -13,3 -10,4 -27.15% | -7,27 -9,83 26.11% | -1,33 -4,73 71.91% | -8,92 | -5,81 | -4,59 | -0,71 | -9,12 |
|
EPS USD | Released Forecast Spread | -0,05 -0,08 35.48% | -0,07 -0,08 15.15% | -0,06 -0,07 14.29% | -0,05 -0,06 13.04% | -0,08 -0,06 -45.45% | -0,09 -0,08 -8% | -0,07 -0,06 -21.74% | -0,04 -0,05 25% | -0,01 -0,03 63.64% | -0,05 | -0,03 | -0,02 | 0,00 | -0,05 |
| Announcement Date | 22/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 04/05/23 | 02/08/23 | 02/11/23 | 05/03/24 | - | - | - | - | - |
More events
Past sector events for Cerus Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CERS Stock
- Calendar Cerus Corporation
